Search for: "Purdue Pharmaceuticals L.P." Results 1 - 20 of 61
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Mar 2024, 7:17 am by Dennis Crouch
Ironically, the underlying Federal Circuit decision that Purdue sought to challenge, Purdue Pharma L.P. v. [read post]
With AmerisourceBergen Drug Corporation, Purdue Pharma L.P., and Endo Pharmaceuticals Inc being sued previously. [read post]
8 Feb 2019, 10:26 am by zbrown
Right now, inside a Massachusetts federal courtroom, Massachusetts attorney general Maura Healey is up against pharmaceutical giant Purdue Pharma LP, maker of the controversial drug OxyContin, and its owners, the Sackler family. [read post]
8 Feb 2019, 10:11 am by Legal Talk Network
Right now, inside a Massachusetts federal courtroom, Massachusetts attorney general Maura Healey is up against pharmaceutical giant Purdue Pharma LP, maker of the controversial drug OxyContin, and its owners, the Sackler family. [read post]
30 Oct 2018, 4:12 pm by Sabrina I. Pacifici
There 80 towns and cities sued several major drug companies under RICO, including AmerisourceBergen Drug Corporation, Purdue Pharma L.P., and Janssen Pharmaceuticals Inc., among others, seeking damages over the opioid crisis. [read post]
26 Sep 2017, 12:46 pm by Associated Press
About a dozen pharmaceutical companies, including Purdue Pharma L.P., Janssen Pharmaceuticals Inc. and Allergan PLC, filed a brief Friday saying they’ve complied with the U.S. [read post]
21 Sep 2017, 6:43 am by Schachtman
For the last 30 years, Campion has been on the faculty in Purdue University. [read post]
13 Jun 2017, 2:55 pm by Lawrence B. Ebert
Purdue lost in the interference for lack of written description:Purdue Pharma L.P. [read post]
8 Feb 2017, 3:09 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
14 Nov 2016, 9:16 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
13 Oct 2016, 6:50 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
18 Sep 2016, 6:03 pm by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
1 Feb 2016, 10:43 am by Lawrence B. Ebert
Plaintiffs-appellantsPurdue Pharma L.P., The P.F. [read post]